Clinical Trial Update: The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Basiliximab as maintenance therapy for stable, noninfectious uveitis; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• Basiliximab (basiliximab)

Snippet

Sponsor: Cerimon Pharmaceuticals | Conditions: Non-infectious Uveitis | Phase 2 | Status: TERMINATED